Article
Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosa.
Stem cell research - 1 May 2017
Sharma Tasneem P, Wiley Luke A, Whitmore S Scott, Anfinson Kristin R, Cranston Cathryn M, Oppedal Douglas J, Daggett Heather T, Mullins Robert F, Tucker Budd A, Stone Edwin M
Abstract excerpt
Retinitis pigmentosa (RP) is a heterogeneous group of monogenic disorders characterized by progressive death of the light-sensing photoreceptor cells of the outer neural retina. We recently identified novel hypomorphic mutations in the tRNA Nucleotidyl Transferase, CCA-Adding 1 (TRNT1) gene that cause early-onset RP. To model this disease in vitro, we generated patient-specific iPSCs and iPSC-derived retinal...
Topics
Join the communities discussing this publication.
